title: Advantages of laparoscopic resection for ileocolic Crohn's disease. Improved outcomes and reduced costs.
abstract: BACKGROUND
  Laparoscopic colorectal procedures are considered to be technically challenging, and there is a lack of consensus regarding the magnitude of their benefits. The laparoscopic approach is generally held to be more expensive. Using a model of a single procedure performed for a single indication (ileocolic resection for Crohn's disease [CD]), we set out to demonstrate the feasibility of this procedure by determining the conversion rate, documenting the patient benefits, and performing a formal cost analysis.
  
  
  METHODS
  Consecutive cases of laparoscopic ileocolic resection for CD were identified (LAP). Case-match methodology identified a series of open laparotomy controls (OPEN) that were matched for five potential confounding criteria: age, gender, diagnosis, type of resection, and date of operation. Pre-, intra-, and postoperative details were gathered. Medical resource utilization was tracked using a standardized database, and all costs were reported in 1999 dollars.
  
  
  RESULTS
  The conversion rate was 5.9%. Resolution of ileus occurred more rapidly in the LAP than in the OPEN group. The time to clears in the LAP group was a median of 0 days (range, 0-4) vs 3.0 days (range, 2-8) in the OPEN group (p = 0.0001). Time to regular diet was 2.0 days (range, 1-6) in the LAP group vs 5.0 days (range, 3-12) in the OPEN group (p = 0.0001). Length of hospital stay was significantly reduced in the LAP group (4.0 days [range, 2-8], vs 7.0 days [range, 3-14], p = 0.0001). The LAP group had significantly lower direct costs ($8684 vs $11,373) and indirect costs ($1358 vs $2349) than the OPEN group (p < 0.001). This resulted in total costs of $9895 for LAP vs $13,268 for OPEN (p < 0.001).
  
  
  CONCLUSIONS
  Laparoscopic ileocolic resection for CD is feasible. There are significant postoperative benefits in terms of resolution of ileus, narcotic use, and hospital stay. This approach translates into cost savings of >$3300 for laparoscopic patients.
authors.affiliation: Division of Colon and Rectal Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. youngfadok.tonia@mayo.edu
authors.forename: T M
authors.initials: TM
authors.lastname: Young-Fadok
authors.forename: K
authors.initials: K
authors.lastname: HallLong
authors.forename: E J
authors.initials: EJ
authors.lastname: McConnell
authors.forename: G
authors.initials: G
authors.lastname: Gomez Rey
authors.forename: R L
authors.initials: RL
authors.lastname: Cabanela
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015992:Body Mass Index; D016022:Case-Control Studies; D003082:Colectomy / Q000191:economics / Q000379:methods; D003092:Colitis / Q000601:surgery; D003365:Costs and Cost Analysis; D003424:Crohn Disease / Q000191:economics / Q000601:surgery*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007079:Ileitis / Q000601:surgery; D010535:Laparoscopy / Q000191:economics / Q000379:methods*; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome